Skip to search.
 BSE Down 0.36% NSE Down 0.40%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.76 Down 0.07(1.20%) 24 Sep 1:30am
|After Hours : 5.76 0.00 (0.00%) 24 Sep 2:17am
Prev Close:5.83
Open:5.83
Bid:5.50 x 1000
Ask:5.90 x 100
1y Target Est:21.00
Beta:1.9423
Earnings Date:31 Oct - 4 Nov (Est.)
Day's Range:5.65 - 5.90
52wk Range:4.45 - 14.93
Volume:1,232,986
Avg Vol (3m):2,155,430
Market Cap:751.66M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 1.20%751.66M
IMGNDown 1.74%246.26M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):102.06
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.34
Quarterly EPS Est (Sep-16) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback